Drug intelligence / Profile preview

pan-ERR modulator

Development stage
Preclinical
Lead developer
Pelagos Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

The pan-ERR modulator program, under development by Pelagos Pharma, focuses on the discovery and optimization of small-molecule pan-modulators (specifically agonists) of estrogen-related receptor (ERR) nuclear receptors (ERRα, ERRβ, and ERRγ). Designed as 'exercise mimetics,' these compounds activate the same beneficial metabolic, mitochondrial, and structure-function pathways typically triggered by aerobic exercise. By promoting mitochondrial biogenesis, enhancing fatty acid oxidation, and improving cellular metabolism, the program aims to address diseases of aging, including heart failure, obesity/sarcopenia, and cognitive decline. The program is currently in the preclinical stage of lead optimization, building upon earlier tool compounds such as SLU-PP-332 and SLU-PP-915, with development candidate (DC) nomination projected for late 2027.

Other names
exercise mimeticpan-ERR agonistpan-ERR modulator
02

Targets

ESRRA (Estrogen-related receptor alpha)ESRRB (Estrogen-related receptor beta)ESRRG (Estrogen-related receptor gamma)

Beyond the preview

Go deeper on pan-ERR modulator.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pan-ERR modulator.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call